中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Asymmetric 1,4-addition of diethylzinc to cyclic enones catalyzed by Cu(I)-chiral sulfonamide-thiophosphoramide ligands and lithium salts ligand

文献类型:期刊论文

作者Shi M(施敏) ; Zhang W(张雯)
刊名Adv. Synth. Catal.
出版日期2005
卷号347期号:4页码:535-540
其他题名磺酰胺和膦酰胺类手性配体和铜盐催化的金属锌试剂和环状不饱和酮的加成反应
通讯作者施敏
英文摘要The chiral sulfonamide-thiophosphoramide ligand L1, prepared from the reaction of (1R,2R)(-)-1,2-cyclohexanediamine with diphenylthiophosphoryl chloride and p-toluenesulfonyl chloride, was used as a chiral ligand in Cu(MeCN)(4)ClO4-promoted catalytic asymmetric addition of diethylzinc to cyclic enones using LiCl as an additive in which up to 90% ee can be realized under mild conditions within 0.5 h. This chiral ligand is stable and recoverable after usual work-up and can be reused in the same catalytic asymmetric reaction. Moreover, it was found that this series of chiral ligands represents a type of S,O-bidentate ligands on the basis of H-1 NMR, P-31 NMR and 13 C NMR spectroscopic investigations. The linear effect of ligand ee and product ee further revealed that the active species is a monomeric Cu(I) complex bearing a single ligand.
学科主题金属有机化学
收录类别SCI
原文出处http://dx.doi.org/10.1002/adsc.200404321
语种英语
公开日期2013-01-09
源URL[http://202.127.28.38/handle/331003/10004]  
专题上海有机化学研究所_金属有机化学国家重点实验室
推荐引用方式
GB/T 7714
Shi M,Zhang W. Asymmetric 1,4-addition of diethylzinc to cyclic enones catalyzed by Cu(I)-chiral sulfonamide-thiophosphoramide ligands and lithium salts ligand[J]. Adv. Synth. Catal.,2005,347(4):535-540.
APA Shi M,&Zhang W.(2005).Asymmetric 1,4-addition of diethylzinc to cyclic enones catalyzed by Cu(I)-chiral sulfonamide-thiophosphoramide ligands and lithium salts ligand.Adv. Synth. Catal.,347(4),535-540.
MLA Shi M,et al."Asymmetric 1,4-addition of diethylzinc to cyclic enones catalyzed by Cu(I)-chiral sulfonamide-thiophosphoramide ligands and lithium salts ligand".Adv. Synth. Catal. 347.4(2005):535-540.

入库方式: OAI收割

来源:上海有机化学研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。